FDAnews
www.fdanews.com/articles/187482-fagron-sterile-services-recalls-syringes-after-labelling-gaffe

Fagron Sterile Services Recalls Syringes After Labelling Gaffe

July 5, 2018

Fagron Sterile Services recalled two lots of its Neostigmine syringes after a customer discovered that some of the syringes were incorrectly labeled at lower doses.

Neostigmine overdoses can cause a range of symptoms from nausea to death. So far, no adverse reactions have been reported, the company said.

The product is used to treat myasthenia gravis, an autoimmune disorder, and as a post-operative drug to help treat or prevent distention or urinary retention as well as the side effects from non-depolarizing neuromuscular blocking agents.

View today's stories